Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2

  1. Xiao-ding Peng1,4,
  2. Pei-Zhang Xu1,4,
  3. Mei-Ling Chen1,
  4. Annett Hahn-Windgassen1,
  5. Jennifer Skeen1,
  6. Joel Jacobs1,
  7. Deepa Sundararajan1,
  8. William S. Chen1,
  9. Susan E. Crawford2,
  10. Kevin G. Coleman3, and
  11. Nissim Hay1,5
  1. 1Department of Molecular Genetics, College of Medicine, University of Illinois at Chicago, Chicago, Illinois 60607, USA; 2Department of Pathology, Northwestern University Medical School, Chicago, Illinois 60611, USA; 3Pfizer Global Research and Development, Groton, Connecticut 06340, USA

Abstract

To elucidate the functions of the serine/threonine kinase Akt/PKB in vivo, we generated mice lacking both akt1 and akt2 genes. Akt1/Akt2 double-knockout (DKO) mice exhibit severe growth deficiency and die shortly after birth. These mice display impaired skin development because of a proliferation defect, severe skeletal muscle atrophy because of a marked decrease in individual muscle cell size, and impaired bone development. These defects are strikingly similar to the phenotypes of IGF-1 receptor-deficient mice and suggest that Akt may serve as the most critical downstream effector of the IGF-1 receptor during development. In addition, Akt1/Akt2 DKO mice display impeded adipogenesis. Specifically, Akt1 and Akt2 are required for the induced expression of PPARγ, the master regulator of adipogenesis, establishing a new essential role for Akt in adipocyte differentiation. Overall, the combined deletion of Akt1 and Akt2 establishes in vivo roles for Akt in cell proliferation, growth, and differentiation. These functions of Akt were uncovered despite the observed lower level of Akt activity mediated by Akt3 in Akt1/Akt2 DKO cells, suggesting that a critical threshold level of Akt activity is required to maintain normal cell proliferation, growth, and differentiation.

Keywords

Footnotes

  • 4 These authors contributed equally to this work.

  • Corresponding author.

  • 5 E-MAIL nhay{at}uic.edu; FAX (312) 355-2032.

  • Article and publication are at http://www.genesdev.org/cgi/doi/10.1101/gad.1089403.

    • Accepted April 8, 2003.
    • Received February 26, 2003.
| Table of Contents

Life Science Alliance